Senior insider sale
Chief Medical Officer at MBX BIOSCIENCES, INC. — senior position signals high conviction
$2.72M
70.60K shares
What this filing means
AZOULAY SALOMON plans to sell 70.60K shares of MBX BIOSCIENCES, INC. valued at approximately $2.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001959173-26-005628
Officer· Chief Medical Officer
Since Feb 2026
70.60K
Shares to sell
$2.72M
Approx. market value
370.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/3/2026
370.00Total acquired370.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/3/2026 | Restricted Stock Vesting Compensation | 370.00 | — |
| Total | 370.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
70K
Market value
$2.69M
5/8/2026
—Completed
Units to sell
231.00
Market value
$6.8K
5/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
370.00
Market value
$24.3K
8/4/2026
Total
Units
70.60K
Value
$2.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/8/2026 | 70K | $2.69M | — | Completed |
5/6/2026 | 231.00 | $6.8K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 370.00 | $24.3K | NASDAQ | Planned |
| Total | 70.60K | $2.72M | ||